MERS-CoV as an emerging respiratory illness: A review of prevention methods

Travel Medicine and Infectious Disease

Volumn 32, Issue , 2019, Pages

  Baharoon, Salim ^a,b   Memish, Ziad A ^c,d,e  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^c Ministry of Health   (Saudi Arabia)

^d ALFAISAL UNIVERSITY   (Saudi Arabia)

^e EMORY UNIVERSITY   (United States)

Author keywords

Infection control; MERS CoV; Outbreaks; Prevention; Saudi Arabia

Indexed keywords

VIRUS VACCINE;

DISEASE TRANSMISSION; HEALTH CARE FACILITY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; POST EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; TRAVEL; VIROLOGY;

EID: 85076228479     PISSN: 14778939     EISSN: 18730442     Source Type: Journal    
DOI: 10.1016/j.tmaid.2019.101520     Document Type: Review

References (126)

1. Corman, V.M., Muth, D., Niemeyer, D., Drosten, C., Hosts and sources of endemic human coronaviruses. Adv Virus Res 100 (2018), 163–188.
2. Al Hajjar, S., Memish, Z.A., McIntosh, K., Middle East respiratory syndrome coronavirus (MERS-CoV): a perpetual challenge. Ann Saudi Med 33:5 (2013), 427–436.
3. Zaki, A.M., Van Boheemen, S., Bestebroer, T.M., Osterhaus, A.D.M.E., Fouchier, R.A.M., Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367 (2012), 1814–1820.
4. Lu, G., Wang, Q., Gao, G.F., Bat-to-human: spike features determining ‘host jump'of coronaviruses SARS-CoV, MERS-CoV, and beyond. Trends Microbiol 23 (2015), 468–478.
5. Chan, J.F.W., Lau, S.K.P., To, K.K.W., Cheng, V.C.C., Woo, P.C.Y., Yuen, K.-Y., Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev 28 (2015), 465–522.
6. Fong, I.W., Emerging Zoonoses. 2017, Emerg Infect Dis 21st Century Springer Int.
7. Graham, R.L., Baric, R.S., Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission. J Virol 84 (2010), 3134–3146.
8. Hilgenfeld, R., Peiris, M., From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses. Antivir Res 100 (2013), 286–295.
9. de Wit, E., van Doremalen, N., Falzarano, D., Munster, V.J., SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol, 14, 2016, 523.
10. Corman, V.M., Jores, J., Meyer, B., Younan, M., Liljander, A., Said, M.Y., et al. Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992–2013. Emerg Infect Dis, 20, 2014, 1319.
11. Chu, D.K.W., Oladipo, J.O., Perera, R.A.P.M., Kuranga, S.A., Chan, S.M.S., Poon, L.L.M., et al. Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria. Euro Surveill, 2015(20), 2015, 30086.
12. Organization WH, Middle East respiratory syndrome coronavirus (MERS-CoV). https://www.who.int/emergencies/mers-cov/en.
13. Assiri, A., Al-Tawfiq, J.A., Al-Rabeeah, A.A., Al-Rabiah, F.A., Al-Hajjar, S., Al-Barrak, A., et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 13 (2013), 752–761.
14. Assiri, A., McGeer, A., Perl, T.M., Price, C.S., Al Rabeeah, A.A., Cummings, D.A.T., et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 369 (2013), 407–416.
15. Hunter, J.C., Nguyen, D., Aden, B., Al Bandar, Z., Al Dhaheri, W., Elkheir, K.A., et al. Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi. Emerg Infect Dis, 22, 2016, 647.
16. Saeed, AA Bin, Abedi, G.R., Alzahrani, A.G., Salameh, I., Abdirizak, F., Alhakeem, R., et al. Surveillance and testing for middle east respiratory syndrome coronavirus, Saudi Arabia, April 2015–February 2016. Emerg Infect Dis(23), 2017, 682.
17. Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, Osong Public Heal Res Perspect 2015 (2015), 269–278, 10.1016/j.phrp.2015.08.006 6.
18. Chafekar, A., Fielding, B.C., MERS-CoV: understanding the latest human coronavirus threat. Viruses, 10, 2018, 93.
19. Virlogeux, V., Fang, V.J., Park, M., Wu, J.T., Cowling, B.J., Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia. Sci Rep, 6, 2016, 35839.
20. Alraddadi, B.M., Watson, J.T., Almarashi, A., Abedi, G.R., Turkistani, A., Sadran, M., et al. Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia. Emerg Infect Dis, 2016(22), 2014, 49.
21. Al-Tawfiq, J.A., Hinedi, K., Ghandour, J., Khairalla, H., Musleh, S., Ujayli, A., et al. Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients. Clin Infect Dis 59 (2014), 160–165.
22. Song, Y., Yang, J.-S., Yoon, H.J., Nam, H.-S., Lee, S.Y., Cheong, H.-K., et al. Asymptomatic Middle East Respiratory Syndrome coronavirus infection using a serologic survey in Korea. Epidemiol Health, 2018, 40.
23. Drosten, C., Seilmaier, M., Corman, V.M., Hartmann, W., Scheible, G., Sack, S., et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis 13 (2013), 745–751.
24. Arabi, Y.M., Arifi, A.A., Balkhy, H.H., Najm, H., Aldawood, A.S., Ghabashi, A., et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 160 (2014), 389–397.
25. Alfaraj, S.H., Al-Tawfiq, J.A., Assiri, A.Y., Alzahrani, N.A., Alanazi, A.A., Memish, Z.A., Clinical predictors of mortality of Middle East Respiratory Syndrome (MERS) infection: a cohort study 2019. Trav Med Infect Dis 29 (2019 May - Jun), 48–50.
26. Saad, M., Omrani, A.S., Baig, K., Bahloul, A., Elzein, F., Matin, M.A., et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis 29 (2014), 301–306.
27. Cauchemez, S., Fraser, C., Van Kerkhove, M.D., Donnelly, C.A., Riley, S., Rambaut, A., et al. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis 14 (2014), 50–56.
28. Memish, Z.A., Al-Tawfiq, J.A., Assiri, A., AlRabiah, F.A., Al Hajjar, S., Albarrak, A., et al. Middle East respiratory syndrome coronavirus disease in children. Pediatr Infect Dis J 33 (2014), 904–906.
29. Al-Tawfiq, J.A., Kattan, R.F., Memish, Z.A., Middle East respiratory syndrome coronavirus disease is rare in children: an update from Saudi Arabia. World J Clin Pediatr, 5, 2016, 391.
30. Alfaraj, S.H., Al-Tawfiq, J.A., Altuwaijri, T.A., Memish, Z.A., Middle East respiratory syndrome coronavirus in pediatrics: a report of seven cases from Saudi Arabia. Front Med 13 (2019), 126–130.
31. Group WHOM-CR, State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans. PLoS Curr, 2013, 5.
32. Oboho, I.K., Tomczyk, S.M., Al-Asmari, A.M., Banjar, A.A., Al-Mugti, H., Aloraini, M.S., et al. 2014 MERS-CoV outbreak in Jeddah—a link to health care facilities. N Engl J Med 372 (2015), 846–854.
33. Amer, H., Alqahtani, A.S., Alaklobi, F., Altayeb, J., Memish, Z.A., Healthcare worker exposure to Middle East respiratory syndrome coronavirus (MERS-CoV): revision of screening strategies urgently needed. Int J Infect Dis 71 (2018), 113–116, 10.1016/j.ijid.2018.04.001.
34. Omrani, A.S., Matin, M.A., Haddad, Q., Al-Nakhli, D., Memish, Z.A., Albarrak, A.M., A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case. Int J Infect Dis 17 (2013), e668–e672.
35. Al-Abdely, H.M., Midgley, C.M., Alkhamis, A.M., Abedi, G.R., Tamin, A., Binder, A.M., et al. Infectious MERS-CoV isolated from a mildly ill patient, Saudi Arabia. Open forum Infect. Dis., 5, 2018, Oxford University Press US p. ofy111.
36. Drosten, C., Meyer, B., Muller, M.A., Corman, V.M., Al-Masri, M., Hossain, R., et al. Transmission of MERS-coronavirus in household contacts. N Engl J Med 371 (2014), 828–835, 10.1056/NEJMoa1405858.
37. Memish, Z.A., Al-Tawfiq, J.A., Makhdoom, H.Q., Al-Rabeeah, A.A., Assiri, A., Alhakeem, R.F., et al. Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study. Clin Microbiol Infect 20 (2014), 469–474.
38. Poissy, J., Goffard, A., Parmentier-Decrucq, E., Favory, R., Kauv, M., Kipnis, E., et al. Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases. J Clin Virol 61 (2014), 275–278.
39. Min, C.-K., Cheon, S., Ha, N.-Y., Sohn, K.M., Kim, Y., Aigerim, A., et al. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep, 6, 2016, 25359.
40. Cotten, M., Watson, S.J., Kellam, P., Al-Rabeeah, A.A., Makhdoom, H.Q., Assiri, A., et al. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet 382 (2013), 1993–2002.
41. Han, H.-J., Wen, H., Zhou, C.-M., Chen, F.-F., Luo, L.-M., Liu, J., et al. Bats as reservoirs of severe emerging infectious diseases. Virus Res 205 (2015), 1–6.
42. Kim, Y.-J., Cho, Y.-J., Kim, D.-W., Yang, J.-S., Kim, H., Park, S., et al. Complete genome sequence of Middle East respiratory syndrome coronavirus KOR/KNIH/002_05_2015, isolated in South Korea. Genome Announc, 3, 2015 e00787–15.
43. Qian, Z., Dominguez, S.R., Holmes, K.V., Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation. PLoS One, 8, 2013, e76469.
44. Hulswit, R.J.G., de Haan, C.A.M., Bosch, B.-J., Coronavirus spike protein and tropism changes. Adv Virus Res 96 (2016), 29–57 Elsevier.
45. Raj, V.S., Mou, H., Smits, S.L., Dekkers, D.H.W., Müller, M.A., Dijkman, R., et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature, 495, 2013, 251.
46. Chen, Y., Rajashankar, K.R., Yang, Y., Agnihothram, S.S., Liu, C., Lin, Y.-L., et al. Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus. J Virol 87 (2013), 10777–10783.
47. Ithete, N.L., Stoffberg, S., Corman, V.M., Cottontail, V.M., Richards, L.R., Schoeman, M.C., et al. Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg Infect Dis, 19, 2013, 1697.
48. Corman, V.M., Ithete, N.L., Richards, L.R., Schoeman, M.C., Preiser, W., Drosten, C., et al. Rooting the phylogenetic tree of middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat. J Virol 88 (2014), 11297–11303.
49. Drexler, J.F., Corman, V.M., Drosten, C., Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS. Antivir Res 101 (2014), 45–56.
50. Yinda, C.K., Ghogomu, S.M., Conceição-Neto, N., Beller, L., Deboutte, W., Vanhulle, E., et al. Cameroonian fruit bats harbor divergent viruses, including rotavirus H, bastroviruses, and picobirnaviruses using an alternative genetic code. Virus Evol, 4, 2018 vey008.
51. Hemida, M.G., Perera, R.A., Al, R.A.J., Kayali, G., Siu, L.Y., Wang, P., et al. Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Euro Surveill Bull Eur Sur Les Mal Transm Eur Commun Dis Bull, 2014, 19.
52. Yang, Y., Du, L., Liu, C., Wang, L., Ma, C., Tang, J., et al. Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus. Proc Natl Acad Sci 111 (2014), 12516–12521.
53. Yang, Y., Liu, C., Du, L., Jiang, S., Shi, Z., Baric, R.S., et al. Two mutations were critical for bat-to-human transmission of Middle East respiratory syndrome coronavirus. J Virol 89 (2015), 9119–9123.
54. Omrani, A.S., Al-Tawfiq, J.A., Memish, Z.A., Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction. Pathog Glob Health 109 (2015), 354–362.
55. Alagaili, A.N., Briese, T., Mishra, N., Kapoor, V., Sameroff, S.C., de Wit, E., et al. Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. mBio, 5, 2014 e00884–14.
56. Briese, T., Mishra, N., Jain, K., Zalmout, I.S., Jabado, O.J., Karesh, W.B., et al. Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia. mBio, 5, 2014 e01146–14.
57. Azhar, E.I., El-Kafrawy, S.A., Farraj, S.A., Hassan, A.M., Al-Saeed, M.S., Hashem, A.M., et al. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med 370:26 (2014 Jun 26), 2499–2505.
58. Memish, Z.A., Cotten, M., Meyer, B., Watson, S.J., Alsahafi, A.J., Rabeeah, Al, et al. A Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia. Emerg Infect Dis 20:6 (2013), 1012–1015 2014 Jun.
59. Azhar, E.I., Hashem, A.M., El-Kafrawy, S.A., Sohrab, S.S., Aburizaiza, A.S., Farraj, S.A., et al. Detection of the Middle East respiratory syndrome coronavirus genome in an air sample originating from a camel barn owned by an infected patient. mBio, 5(4), 2014 Jul 22 e01450–14.
60. Memish, Z.A., Mishra, N., Olival, K.J., Fagbo, S.F., Kapoor, V., Epstein, J.H., et al. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis, 19, 2013, 1819.
61. Alshukairi, A.N., Zheng, J., Zhao, J., Nehdi, A., Baharoon, S.A., Layqah, L., et al. High prevalence of MERS-CoV infection in camel workers in Saudi Arabia. mBio, 9, 2018 e01985–18.
62. Kandeil, A., Gomaa, M., Shehata, M., El-Taweel, A., Kayed, A.E., Abiadh, A., et al. Middle East respiratory syndrome coronavirus infection in non-camelid domestic mammals. Emerg Microb Infect 8 (2019), 103–108.
63. Gossner, C., Danielson, N., Gervelmeyer, A., Berthe, F., Faye, B., Kaasik Aaslav, K., et al. Human–dromedary camel interactions and the risk of acquiring zoonotic Middle East respiratory syndrome coronavirus infection. Zoonoses Public Health 63 (2016), 1–9.
64. Funk, A.L., Goutard, F.L., Miguel, E., Bourgarel, M., Chevalier, V., Faye, B., et al. MERS-CoV at the animal–human interface: inputs on exposure pathways from an expert-opinion elicitation. Front Vet Sci, 3, 2016, 88.
65. Thomas, H.L., Zhao, H., Green, H.K., Boddington, N.L., Carvalho, C.F.A., Osman, H.K., et al. Enhanced MERS coronavirus surveillance of travelers from the Middle East to England. Emerg Infect Dis, 20, 2014, 1562.
66. Ryu, S., Kim, J.J., Cowling, B.J., Kim, C., Surveillance and public health response for travelers returning from MERS-CoV affected countries to Gyeonggi Province, Korea, 2016-2017. Trav Med Infect Dis, 2018 Nov 9, 101350, 10.1016/j.tmaid.2018.11.006.
67. Müller, M.A., Meyer, B., Corman, V.M., Al-Masri, M., Turkestani, A., Ritz, D., et al. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis 15 (2015), 559–564.
68. Al-Tawfiq, J.A., Memish, Z.A., Lack of seasonal variation of Middle East respiratory syndrome coronavirus (MERS-CoV). 2018.
69. Nassar, M.S., Bakhrebah, M.A., Meo, S.A., Alsuabeyl, M.S., Zaher, W.A., Global seasonal occurrence of middle east respiratory syndrome coronavirus (MERS-CoV) infection. Eur Rev Med Pharmacol Sci 22 (2018), 3913–3918.
70. Sharif-Yakan, A., Kanj, S.S., Emergence of MERS-CoV in the Middle East: origins, transmission, treatment, and perspectives. PLoS Pathog, 10, 2014, e1004457.
71. Choe, P.G., Perera, R., Park, W.B., Song, K.-H., Bang, J.H., Kim, E.S., et al. MERS-CoV antibody responses 1 year after symptom onset, South Korea. Emerg Infect Dis, 2017(23), 2015, 1079.
72. Al-Tawfiq, J.A., Memish, Z.A., Drivers of MERS-CoV transmission: what do we know?. Expert Rev Respir Med 10 (2016), 331–338.
73. Alfaraj, S.H., Al-Tawfiq, J.A., Altuwaijri, T.A., Alanazi, M., Alzahrani, N., Memish, Z.A., Middle East respiratory syndrome coronavirus transmission among health care workers: implication for infection control. Am J Infect Contr 46 (2018), 165–168.
74. Chowell, G., Abdirizak, F., Lee, S., Lee, J., Jung, E., Nishiura, H., et al. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC Med, 13, 2015, 210.
75. Corman, V.M., Albarrak, A.M., Omrani, A.S., Albarrak, M.M., Farah, M.E., Almasri, M., et al. Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection. Clin Infect Dis 62 (2015), 477–483.
76. Al-Tawfiq, J.A., Auwaerter, P.G., Healthcare-associated infections: the hallmark of Middle East respiratory syndrome coronavirus with review of the literature. J Hosp Infect 101 (2019), 20–29.
77. Al-Gethamy, M., Corman, V.M., Hussain, R., Al-Tawfiq, J.A., Drosten, C., Memish, Z.A., A case of long-term excretion and subclinical infection with Middle East respiratory syndrome coronavirus in a healthcare worker. Clin Infect Dis 60 (2014), 973–974.
78. Memish, Z.A., Assiri, A.M., Al-Tawfiq, J.A., Middle East respiratory syndrome coronavirus (MERS-CoV) viral shedding in the respiratory tract: an observational analysis with infection control implications. Int J Infect Dis 29 (2014), 307–308.
79. Gardner, E.G., Kelton, D., Poljak, Z., Van Kerkhove, M., von Dobschuetz, S., Greer, A.L., A case-crossover analysis of the impact of weather on primary cases of Middle East respiratory syndrome. BMC Infect Dis, 19, 2019, 113.
80. Alharbi, N.K., Padron-Regalado, E., Thompson, C.P., Kupke, A., Wells, D., Sloan, M.A., et al. ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice. Vaccine 35 (2017), 3780–3788.
81. Haagmans, B.L., van den Brand, J.M.A., Raj, V.S., Volz, A., Wohlsein, P., Smits, S.L., et al. An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels. Science 351:80 (2016), 77–81.
82. Almutairi, S.E., Boujenane, I., Musaad, A., Awad-Acharari, F., Non-genetic factors influencing reproductive traits and calving weight in Saudi camels. Trop Anim Health Prod 42 (2010), 1087–1092.
83. Wernery, U., Camelid immunoglobulins and their importance for the new-born–a review. J Vet Med Ser B 48 (2001), 561–568.
84. Martinez-Bakker, M., Bakker, K.M., King, A.A., Rohani, P., Human birth seasonality: latitudinal gradient and interplay with childhood disease dynamics. Proc R Soc B Biol Sci, 281, 2014, 20132438.
85. Hakawi, A., 1. World Health Organization. Home care for patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection presenting with mild symptoms and management of contacts: interim guidance. No. WHO/MERS/IPC/18.1. 2018, World Health Organization, 2018.
86. Lai, M.Y.Y., Cheng, P.K.C., Lim, W.W.L., Survival of severe acute respiratory syndrome coronavirus. Clin Infect Dis 41 (2005), e67–71.
87. Al-Hazmi, A., Gosadi, I., Somily, A., Alsubaie, S., Saeed A Bin. Knowledge, attitude and practice of secondary schools and university students toward Middle East Respiratory Syndrome epidemic in Saudi Arabia: a cross-sectional study. Saudi J Biol Sci 25 (2018), 572–577.
88. Al Mohaissen, M., Awareness among a Saudi Arabian university community of Middle East respiratory syndrome coronavirus following an outbreak. EMHJ-Eastern Mediterr Heal J 23 (2017), 351–360.
89. Van Doremalen, N., Bushmaker, T., Munster, V.J., Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions. Euro Surveill, 18, 2013, 20590.
90. Kang, C.K., Song, K.-H., Choe, P.G., Park, W.B., Bang, J.H., Kim, E.S., et al. Clinical and epidemiologic characteristics of spreaders of Middle East respiratory syndrome coronavirus during the 2015 outbreak in Korea. J Korean Med Sci 32 (2017), 744–749.
91. Cho, S.Y., Kang, J.-M., Ha, Y.E., Park, G.E., Lee, J.Y., Ko, J.-H., et al. MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. Lancet 388 (2016), 994–1001.
92. Alanazi, K.H., Killerby, M.E., Biggs, H.M., Abedi, G.R., Jokhdar, H., Alsharef, A.A., et al. Scope and extent of healthcare-associated Middle East respiratory syndrome coronavirus transmission during two contemporaneous outbreaks in Riyadh, Saudi Arabia. Infect Control Hosp Epidemiol 2019:40 (2017), 79–88.
93. Sung, M., Jo, S., Lee, S.-E., Ki, M., Choi, B., Hong, J., Airflow as a possible transmission route of Middle East respiratory syndrome at an initial outbreak hospital in Korea. Int J Environ Res Public Health, 15, 2018, 2757.
94. Xie, X., Li, Y., Chwang, A.T., Ho, P.L., Seto, W.H., How far droplets can move in indoor environments–revisiting the Wells evaporation-falling curve. Indoor Air 17 (2007), 211–225.
95. WHO, Essential environmental health standards in health care. https://www.who.int/water_sanitation_health/publications/ehs_hc/en/.
96. WHO, Natural ventilation for infection control in health-care settings. https://www.who.int/water_sanitation_health/publications/natural_ventilation/en/.
97. Kim, J.Y., Song, J.Y., Yoon, Y.K., Choi, S.-H., Song, Y.G., Kim, S.-R., et al. Middle East respiratory syndrome infection control and prevention guideline for healthcare facilities. Infect Chemother 47 (2015), 278–302.
98. Al-Tawfiq, J.A., Rabaan, A.A., Hinedi, K., Influenza is more common than Middle East Respiratory Syndrome Coronavirus (MERS-CoV) among hospitalized adult Saudi patients. Trav Med Infect Dis 20 (2017 Nov - Dec), 56–60, 10.1016/j.tmaid.2017.10.004.
99. Ahmed, A.E., Al-Jahdali, H., Alshukairi, A.N., Alaqeel, M., Siddiq, S.S., Alsaab, H., et al. Early identification of pneumonia patients at increased risk of Middle East respiratory syndrome coronavirus infection in Saudi Arabia. Int J Infect Dis 70 (2018), 51–56.
100. Kapoor, M., Pringle, K., Kumar, A., Dearth, S., Liu, L., Lovchik, J., et al. Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States. Clin Infect Dis 59 (2014), 1511–1518.
101. Park, G.E., Ko, J.-H., Peck, K.R., Lee, J.Y., Lee, J.Y., Cho, S.Y., et al. Control of an outbreak of Middle East respiratory syndrome in a tertiary hospital in Korea. Ann Intern Med 165 (2016), 87–93.
102. Stirling, B., Communicating the changing role of a nurse in an epidemic: the example of the MERS-CoV outbreak in Saudi Arabia. J Health Commun, 02, 2017, 10.4172/2472-1654.100070.
103. Al-Tawfiq, J.A., Abdrabalnabi, R., Taher, A., Mathew, S., Rahman, K.A., Infection control influence of Middle East respiratory syndrome coronavirus: a hospital-based analysis. Am J Infect Contr 47 (2019), 431–434.
104. Kim, Y., Healthcare policy and healthcare utilization behavior to improve hospital infection control after the Middle East respiratory syndrome outbreak. J Korean Med Assoc Uisa Hyophoe Chi, 2015, 58.
105. Al-Tawfiq, J.A., Rothwell, S., Mcgregor, H.A., Khouri, Z.A., A multi-faceted approach of a nursing led education in response to MERS-CoV infection. J Infect Public Health 11 (2018), 260–264.
106. Bermingham, A., Chand, M.A., Brown, C.S., Aarons, E., Tong, C., Langrish, C., et al. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill(17), 2012, 20290.
107. Buchholz, U., Müller, M.A., Nitsche, A., Sanewski, A., Wevering, N., Bauer-Balci, T., et al. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012, 2013.
108. IATA, Air passenger market analysis. https://www.iata.org/whatwedo/Documents/economics/passenger-analysis-dec-2014.pdf, 2014.
109. Hoda, J., Identification of information types and sources by the public for promoting awareness of Middle East respiratory syndrome coronavirus in Saudi Arabia. Health Educ Res 31 (2015), 12–23.
110. Aldohyan, M., Al-Rawashdeh, N., Sakr, F.M., Rahman, S., Alfarhan, A.I., Salam, M., The perceived effectiveness of MERS-CoV educational programs and knowledge transfer among primary healthcare workers: a cross-sectional survey. BMC Infect Dis, 19, 2019, 273.
111. Farag, E.A.B., Nour, M., El Idrissi, A., Berrada, J., Moustafa, A., Mehmood, M., et al. Survey on implementation of one health approach for MERS-CoV preparedness and control in Gulf cooperation council and Middle East countries. Emerg Infect Dis, 2019, 25.
112. Vergara-Alert, J., Vidal, E., Bensaid, A., Segalés, J., Searching for animal models and potential target species for emerging pathogens: experience gained from Middle East respiratory syndrome (MERS) coronavirus. One Heal 3 (2017), 34–40.
113. Zhao, J., Alshukairi, A.N., Baharoon, S.A., Ahmed, W.A., Bokhari, A.A., Nehdi, A.M., et al. Recovery from the Middle East respiratory syndrome is associated with antibody and T cell responses. Sci Immunol, 2, 2017 eaan5393.
114. Modjarrad, K., MERS-CoV vaccine candidates in development: the current landscape. Vaccine 34 (2016), 2982–2987.
115. Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., Jiang, S., The spike protein of SARS-CoV—a target for vaccine and therapeutic development. Nat Rev Microbiol, 7, 2009, 226.
116. Adney, D.R., Wang, L., van Doremalen, N., Shi, W., Zhang, Y., Kong, W.-P., et al. Efficacy of an adjuvanted Middle East respiratory syndrome coronavirus spike Protein Vaccine in dromedary camels and alpacas. Viruses, 11, 2019, 212.
117. Agrawal, A.S., Tao, X., Algaissi, A., Garron, T., Narayanan, K., Peng, B.-H., et al. Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus. Hum Vaccines Immunother 12 (2016), 2351–2356.
118. Park, S.Y., Lee, J.S., Son, J.S., Ko, J.H., Peck, K.R., Jung, Y., et al. Post-exposure prophylaxis for Middle East respiratory syndrome in healthcare workers. J Hosp Infect 101 (2019), 42–46.
119. Houser, K.V., Gretebeck, L., Ying, T., Wang, Y., Vogel, L., Lamirande, E.W., et al. Prophylaxis with a Middle East respiratory syndrome coronavirus (MERS-CoV)–specific human monoclonal antibody protects rabbits from MERS-CoV infection. J Infect Dis 213 (2016), 1557–1561.
120. Widjaja, I., Wang, C., van Haperen, R., Gutiérrez-Álvarez, J., van Dieren, B., Okba, N.M.A., et al. Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein. Emerg Microb Infect 8 (2019), 516–530.
121. Corti, D., Zhao, J., Pedotti, M., Simonelli, L., Agnihothram, S., Fett, C., et al. Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus. Proc Natl Acad Sci 112 (2015), 10473–10478.
122. Du, L., Zhao, G., Yang, Y., Qiu, H., Wang, L., Kou, Z., et al. A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein. J Virol 88 (2014), 7045–7053.
123. Jiang, L., Wang, N., Zuo, T., Shi, X., Poon, K.-M.V., Wu, Y., et al. Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein. Sci Transl Med, 6, 2014 234ra59-234ra59.
124. Qiu, H., Sun, S., Xiao, H., Feng, J., Guo, Y., Tai, W., et al. Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection. Antivir Res 132 (2016), 141–148.
125. Beigel, J.H., Voell, J., Kumar, P., Raviprakash, K., Wu, H., Jiao, J.-A., et al. Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study. Lancet Infect Dis 18 (2018), 410–418.
126. Wang, L., Shi, W., Chappell, J.D., Joyce, M.G., Zhang, Y., Kanekiyo, M., et al. Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on the Middle East respiratory syndrome coronavirus spike glycoprotein to avoid neutralization escape. J Virol 92 (2018), e02002–e02017.